European Commission approves agreement with Janssen for supply of 200 million doses of its Covid-19 vaccine candidate

In the Advance Purchase Agreement, the doses will be supplied following approval/authorisation; EU member states also have the option to secure up to 200 million additional doses. A single dose of the vaccine is currently being evaluated in the ENSEMBLE Phase III trial.

Source:

Biospace Inc.